These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 2857154)
1. Antibodies to Bordetella pertussis in human colostrum and their protective activity against aerosol infection of mice. Oda M; Cowell JL; Burstyn DG; Thaib S; Manclark CR Infect Immun; 1985 Feb; 47(2):441-5. PubMed ID: 2857154 [TBL] [Abstract][Full Text] [Related]
2. Protective activities in mice of monoclonal antibodies against pertussis toxin. Sato H; Sato Y Infect Immun; 1990 Oct; 58(10):3369-74. PubMed ID: 1698179 [TBL] [Abstract][Full Text] [Related]
3. Protective activities of the filamentous hemagglutinin and the lymphocytosis-promoting factor of Bordetella pertussis in mice. Oda M; Cowell JL; Burstyn DG; Manclark CR J Infect Dis; 1984 Dec; 150(6):823-33. PubMed ID: 6094673 [TBL] [Abstract][Full Text] [Related]
4. Serological response to filamentous hemagglutinin and lymphocytosis-promoting toxin of Bordetella pertussis. Burstyn DG; Baraff LJ; Peppler MS; Leake RD; St Geme J; Manclark CR Infect Immun; 1983 Sep; 41(3):1150-6. PubMed ID: 6309662 [TBL] [Abstract][Full Text] [Related]
5. Bordetella pertussis infection in mice: correlation of specific antibodies against two antigens, pertussis toxin, and filamentous hemagglutinin with mouse protectivity in an intracerebral or aerosol challenge system. Sato H; Sato Y Infect Immun; 1984 Nov; 46(2):415-21. PubMed ID: 6542069 [TBL] [Abstract][Full Text] [Related]
6. Specific anti-Bordetella pertussis activities in human blood examined by enzyme-linked immunoassay and biological assay. Marley PB; Wilson JV; Habel H; Blaskett A Dev Biol Stand; 1985; 61():341-52. PubMed ID: 2872123 [TBL] [Abstract][Full Text] [Related]
7. Bordetella pertussis filamentous hemagglutinin: evaluation as a protective antigen and colonization factor in a mouse respiratory infection model. Kimura A; Mountzouros KT; Relman DA; Falkow S; Cowell JL Infect Immun; 1990 Jan; 58(1):7-16. PubMed ID: 2294058 [TBL] [Abstract][Full Text] [Related]
8. Protective antigens of Bordetella pertussis mouse-protection test against intracerebral and aerosol challenge of B. pertussis. Sato H; Sato Y Dev Biol Stand; 1985; 61():461-7. PubMed ID: 2872127 [TBL] [Abstract][Full Text] [Related]
9. Passive acquisition of protective antibodies reactive with Bordetella pertussis in newborns via placental transfer and breast-feeding. Quinello C; Quintilio W; Carneiro-Sampaio M; Palmeira P Scand J Immunol; 2010 Jul; 72(1):66-73. PubMed ID: 20591078 [TBL] [Abstract][Full Text] [Related]
10. Bordetella pertussis FHA antibodies in maternal/infants sera and colostrum. Helmy MF; Hammam M; el Kholy MS; Guirguis N J Egypt Public Health Assoc; 1992; 67(1-2):195-212. PubMed ID: 1295946 [TBL] [Abstract][Full Text] [Related]
11. Protection against intranasal infection of mice with Bordetella pertussis. Robinson A; Ashworth LA; Baskerville A; Irons LI Dev Biol Stand; 1985; 61():165-72. PubMed ID: 2872102 [TBL] [Abstract][Full Text] [Related]
12. [Serum immunoglobulin IgG subclass distribution of antibody responses to pertussis toxin and filamentous hemagglutinin of Bordetella pertussis in patients with whooping cough]. Rastawicki W; SmietaĆska K; Rokosz-Chudziak N; Jagielski M Med Dosw Mikrobiol; 2013; 65(4):269-74. PubMed ID: 24730215 [TBL] [Abstract][Full Text] [Related]
13. Reciprocal protective immunity against Bordetella pertussis and Bordetella parapertussis in a murine model of respiratory infection. Watanabe M; Nagai M Infect Immun; 2001 Nov; 69(11):6981-6. PubMed ID: 11598073 [TBL] [Abstract][Full Text] [Related]
14. Pertussis toxin: the cause of the harmful effects and prolonged immunity of whooping cough. A hypothesis. Pittman M Rev Infect Dis; 1979; 1(3):401-12. PubMed ID: 233166 [TBL] [Abstract][Full Text] [Related]
15. Monoclonal antibody against pertussis toxin: effect on toxin activity and pertussis infections. Sato H; Ito A; Chiba J; Sato Y Infect Immun; 1984 Nov; 46(2):422-8. PubMed ID: 6094351 [TBL] [Abstract][Full Text] [Related]
16. Role of antibody to leukocytosis-promoting factor hemagglutinin and to filamentous hemagglutinin in immunity to pertussis. Sato Y; Izumiya K; Sato H; Cowell JL; Manclark CR Infect Immun; 1981 Mar; 31(3):1223-31. PubMed ID: 6262248 [TBL] [Abstract][Full Text] [Related]
17. Eighty-kilodalton N-terminal moiety of Bordetella pertussis filamentous hemagglutinin: adherence, immunogenicity, and protective role. Alonso S; Reveneau N; Pethe K; Locht C Infect Immun; 2002 Aug; 70(8):4142-7. PubMed ID: 12117922 [TBL] [Abstract][Full Text] [Related]
18. Assessment of safety and efficacy against Bordetella pertussis of a new tetanus-reduced dose diphtheria-acellular pertussis vaccine in a murine model. Kwon HJ; Han SB; Kim BR; Kang KR; Huh DH; Choi GS; Ahn DH; Kang JH BMC Infect Dis; 2017 Apr; 17(1):247. PubMed ID: 28376777 [TBL] [Abstract][Full Text] [Related]
19. Serum IgG, IgA, and IgM responses to pertussis toxin, filamentous hemagglutinin, and agglutinogens 2 and 3 after infection with Bordetella pertussis and immunization with whole-cell pertussis vaccine. Thomas MG; Ashworth LA; Miller E; Lambert HP J Infect Dis; 1989 Nov; 160(5):838-45. PubMed ID: 2572651 [TBL] [Abstract][Full Text] [Related]
20. History of whooping cough in nonvaccinated Swedish children, related to serum antibodies to pertussis toxin and filamentous hemagglutinin. Zackrisson G; Taranger J; Trollfors B J Pediatr; 1990 Feb; 116(2):190-4. PubMed ID: 2299488 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]